GSK Investigational Site

Skedsmokorset N-2020

0 studies enrolling now · 3 studies all time

What they study most

Diabetes Mellitus, Type 2, Pulmonary Disease, Chronic Obstructive

Studies at this site

• A 24-week Evaluation of GSK573719/Vilanterol (125/25mcg) and Components in COPD — Completed
• Diabetes Study With Rosiglitazone Monotherapy Versus Metformin Or Glyburide/Glibenclamide — Completed
• Thiazolidinedione Intervention With Vitamin D Evaluation — Stopped early